(Nasdaq: KRON), a company dedicated to developing small ... for multiple myeloma at the American Society of Hematology (ASH) Annual Meeting taking place in San Diego, California from December ...

"Our strategic investments have helped advance more than 70% of blood cancer treatments approved by the FDA over the past 20 years and I am encouraged to see how the latest data at ASH will lead ...